A new multiple gene expression profile test developed by scientists helps predict the presence of harmful BRCA1 or BRCA2 mutations. "This novel technology aims to provide a layer of information regarding the cell functionality aspect of BRCA mutations that could greatly enhance the doctor's ability to identify high-risk carriers," said Asher Y. Salmon, M.D., a breast cancer specialist at the Hadassah Hebrew University Medical Center in Jerusalem, Israel. ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment